PYROJAS INC
PyroTIMER Technology: Enabling T-Cell Persistence in Immunosuppressive Tumor Microenvironments
PyroTIMER Technology: Enabling T-Cell Persistence in Immunosuppressive Tumor Microenvironments is a funding opportunity from PYROJAS INC, up to 999283, closing August 31, 2027.
Aug 31, 2027
(396d left)Overview
Abstract The challenge of effectively treating cancer is further complicated by the limitations of current CAR-T cell therapies, especially when confronted with the immunosuppressive tumor microenvironment (TIME). Central to this issue is the transforming growth factor-beta (TGF-β), which induces T cell exhaustion…